1.24
-0.01 (-0.80%)
Previous Close | 1.25 |
Open | 1.26 |
Volume | 1,745,740 |
Avg. Volume (3M) | 1,231,123 |
Market Cap | 297,231,744 |
Price / Sales | 51.50 |
Price / Book | 71.66 |
52 Weeks Range | |
Earnings Date | 21 Feb 2025 - 25 Feb 2025 |
Profit Margin | -135.10% |
Operating Margin (TTM) | -140.87% |
Diluted EPS (TTM) | -0.040 |
Quarterly Revenue Growth (YOY) | 15.10% |
Total Debt/Equity (MRQ) | 15.22% |
Current Ratio (MRQ) | 4.34 |
Operating Cash Flow (TTM) | -6.51 M |
Levered Free Cash Flow (TTM) | -4.91 M |
Return on Assets (TTM) | -25.04% |
Return on Equity (TTM) | -134.46% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (AU) | Mixed | Mixed |
Biotechnology (Global) | Mixed | Mixed | |
Stock | ORTHOCELL FPO [OCC] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -3.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | 4.0 |
Average | 0.25 |
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir which is a collagen wrap used in peripheral nerve repair; and OrthoACI an implantation used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline such as Tendon Cell Therapy and Collagen Medical Device Platform. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Growth |
% Held by Insiders | 21.75% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |